Kane Biotech Inc (KNE) - Medical Equipment - Deals and Alliances Profile
October 2018
39
About the Report
About the Report
Summary
Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develops human health products, animal health products, medical device coating and hard surface disinfectant. Kane Biotech also develops shampoos and skin care formulations for human skin infections including seborrheic dermatitis. The company serves industrial, human and animal healthcare industries. It conducts research and development programs through its on-site CL2 biofilm research laboratory in Canada. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.
Kane Biotech Inc (KNE)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Kane Biotech Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kane Biotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kane Biotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kane Biotech Inc, Medical Equipment, Deal Details 10
Partnerships 10
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 10
Equity Offering 11
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 11
Kane Biotech Raises USD3 Million in Private Placement of Units 12
Kane Biotech Raises USD0.5 Million in First Tranche of Private Placement of Shares 13
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 14
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 15
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 16
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 17
Kane Biotech Completes Private Placement Of Units For USD 1.5 Million 19
Debt Offering 20
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 20
Kane Biotech Inc-Key Competitors 21
Kane Biotech Inc-Key Employees 22
Kane Biotech Inc-Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Aug 21, 2018: Kane Biotech announces second quarter 2018 financial results 24
May 17, 2018: Kane Biotech Announces First Quarter 2018 Financial Results, Granting of Options and Investor Relations Improvements 26
Mar 21, 2018: Kane Biotech-2017 Year End and Fourth Quarter Financial Results and Business Update 27
Nov 14, 2017: Kane Biotech-Q3 2017 Financial Results, Resignation of Director and Granting of Options 29
Aug 16, 2017: Kane Biotech-Q2 2017 Financial Results 30
May 17, 2017: Kane Biotech-Q1 2017 Financial Reports 31
Corporate Communications 32
Sep 24, 2018: Kane Biotech announces formation of scientific advisory board 32
Sep 11, 2018: Kane Biotech announces CEO resignation 33
Jul 17, 2018: Kane Biotech Announces Closing of Loan Transaction 34
May 22, 2018: Kane Biotech Appoints Pharmaceutical Executive Rashieda Gluck to Board of Directors 35
Sep 05, 2017: Kane Biotech Announces New Chief Financial Officer 36
Legal and Regulatory 37
Feb 26, 2018: Kane Biotech Sues Nestle 37
Other Significant Developments 38
Aug 09, 2018: Kane Biotech retains strategic expert in securing non-dilutive funding opportunities in the United States 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Figure
List of Figures
Kane Biotech Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Kane Biotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Kane Biotech Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Kane Biotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Kane Biotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Kane Biotech Inc, Medical Equipment, Key Facts, 2017 2
Kane Biotech Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Kane Biotech Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Kane Biotech Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Kane Biotech Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Kane Biotech Inc, Deals By Market, 2012 to YTD 2018 8
Kane Biotech Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 10
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 11
Kane Biotech Raises USD3 Million in Private Placement of Units 12
Kane Biotech Raises USD0.5 Million in First Tranche of Private Placement of Shares 13
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 14
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 15
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 16
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 17
Kane Biotech Completes Private Placement Of Units For USD 1.5 Million 19
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 20
Kane Biotech Inc, Key Competitors 21
Kane Biotech Inc, Key Employees 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.